| scholarly article | Q13442814 |
| P50 | author | Yenela García | Q61167304 |
| P2093 | author name string | Roberto Menéndez | |
| Teidy García | |||
| Dasha Fuentes | |||
| Nidia Fernández | |||
| Ana Ruth Morales | |||
| P2860 | cites work | Alzheimer Disease in the US Population | Q22253055 |
| Familial apolipoprotein E deficiency | Q24299817 | ||
| Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms | Q27023109 | ||
| Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age | Q27300821 | ||
| Biochemical and cognitive studies of apolipoprotein-E-deficient mice. | Q52048143 | ||
| Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. | Q52051272 | ||
| 2013 Alzheimer's disease facts and figures | Q86421768 | ||
| Repeated exposure to rats has persistent genotype-dependent effects on learning and locomotor activity of apolipoprotein E knockout and C57Bl/6 mice. | Q43349030 | ||
| Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice | Q43581885 | ||
| CNS synaptogenesis promoted by glia-derived cholesterol | Q43794738 | ||
| Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue | Q44175709 | ||
| Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age. | Q45101568 | ||
| Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. | Q46001228 | ||
| High cholesterol level is essential for myelin membrane growth | Q46406733 | ||
| Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice | Q46438248 | ||
| Neurodegeneration in the central nervous system of apoE-deficient mice | Q46455236 | ||
| Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse | Q48024701 | ||
| Role of cholinergic neurotransmission in the amygdala on performances of passive avoidance learning in mice | Q48146255 | ||
| T-maze alternation in the rodent | Q48218933 | ||
| Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks | Q48336938 | ||
| Effect of training on motor abilities of heterozygous staggerer mutant (Rora(+)/Rora(sg)) mice during aging | Q48346451 | ||
| Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | Q48469356 | ||
| Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury | Q48624330 | ||
| Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. | Q48759623 | ||
| Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging | Q49239959 | ||
| Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
| Apolipoprotein E: far more than a lipid transport protein | Q28204471 | ||
| Incidence of dementia: does gender make a difference? | Q28205517 | ||
| Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy | Q28282855 | ||
| Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 | ||
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve | Q28579544 | ||
| Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1 | Q28595044 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females | Q33563135 | ||
| Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. | Q33717326 | ||
| The association of APOE genotype with cognitive function in persons aged 35 years or older | Q34081529 | ||
| Apolipoprotein E: From lipid transport to neurobiology | Q34497951 | ||
| Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system | Q34559847 | ||
| The role of apolipoprotein E in Alzheimer's disease | Q34603092 | ||
| Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect | Q34619645 | ||
| The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review | Q35071470 | ||
| Cholesterol homeostasis and function in neurons of the central nervous system | Q35178066 | ||
| Diabetes, Alzheimer's disease and apolipoprotein genotype | Q35211246 | ||
| Vascular risk and genetics of sporadic late-onset Alzheimer's disease | Q35624963 | ||
| ApoE genotype accounts for the vast majority of AD risk and AD pathology | Q35789660 | ||
| Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal | Q35836597 | ||
| The novel object recognition memory: neurobiology, test procedure, and its modifications | Q35904451 | ||
| The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory | Q35909381 | ||
| Obesity and hypertriglyceridemia produce cognitive impairment | Q36578894 | ||
| Vascular risk factors, cognitive decline, and dementia | Q36812802 | ||
| Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells | Q37011453 | ||
| Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis | Q37151717 | ||
| Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice | Q37290226 | ||
| The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies | Q37732553 | ||
| Men and mice: Relating their ages | Q38643990 | ||
| A Proposed Test Battery and Constellations of Specific Behavioral Paradigms to Investigate the Behavioral Phenotypes of Transgenic and Knockout Mice | Q41523132 | ||
| Differential neurotrophic effects of apolipoprotein E in aged transgenic mice | Q41664893 | ||
| Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. | Q41671941 | ||
| Apolipoprotein E and cognitive performance | Q41727967 | ||
| M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice. | Q42454624 | ||
| Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury | Q42456741 | ||
| Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology | Q42655700 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | knockout mouse | Q1364740 |
| P577 | publication date | 2018-03-03 | |
| P1433 | published in | Behavioral sciences (Basel, Switzerland) | Q27724027 |
| P1476 | title | Age-Related Changes in the Behavior of Apolipoprotein E Knockout Mice. | |
| P478 | volume | 8 |
| Q89972211 | Apolipoprotein E regulates the maturation of injury-induced adult-born hippocampal neurons following traumatic brain injury | cites work | P2860 |
Search more.